*By Christian Smith* No matter which judge President Donald Trump chooses from his Supreme Court shortlist, they will all have a similar impact on America's highest court, says UC-Irvine law professor Rick Hasen. "They're all very conservative," Hasen said of federal judges Brett Kavanaugh, Raymond Kethledge, and Amy Coney Barrett, whose names are [most often cited](https://www.washingtonpost.com/politics/schumer-urges-trump-to-tap-merrick-garland-for-supreme-court/2018/07/05/ca12f0be-805e-11e8-b0ef-fffcabeff946_story.html?utm_term=.f37ee02ac02c) as being at the top of the president's list to fill the seat being vacated by Justice Anthony Kennedy. "They're all likely to be on the same side on issues involving abortion, on issues involving voting rights, on issues involving affirmative action. The kinds of things where Justice Kennedy was the swing justice, all three of these are likely to be pretty much the same." Judging from the comments of TV pundits and news reporters, the betting seems strong that Trump will wind up choosing Judge Kavanaugh, a federal appeals court judge who sits on the District of Columbia circuit. Hasen says picking Kavanaugh would make sense because "he's very much like Neil Gorsuch," Trump's first Supreme Court nominee, who, like Kavanaugh, also has "very well respected Ivy League pedigree." The eventual nominee will only need 50 votes to be confirmed, thanks to rules adopted by Senate leadership in 2017. Vice President Mike Pence would serve as the tiebreaker if the votes are split. Two Senators who could make or break any of these nominees' chances are Sen. Lisa Murkowski (R-AK) and Sen. Susan Collins (R-ME). Both are pro-choice Republicans, which means the question of overturning Roe v. Wade, the landmark 1973 Supreme Court case establishing a woman's right to have an abortion, will likely take center stage in the confirmation hearing process. President Trump is expected to announce his nominee in a prime-time ceremony Monday night. For the full segment [click here.](https://cheddar.com/videos/president-trumps-supreme-court-shortlist-gets-shorter)

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More